Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /servlet/* Sitemap: |
Title | Dual I-O Therapy Efficacy | OPDIVO® |
Description | Set out towards a future dual I-O can Find information about OPDIVO® (nivolumab) + YERVOY® (ipilimumab) treatment in melanoma, RCC, and NSCLC. Please see Indications and Important Safety |
Keywords | N/A |
WebSite | opdivocombotherapy.com |
Host IP | 165.89.235.20 |
Location | United States |
Site | Rank |
US$868
Last updated: 2023-05-01 06:48:50
opdivocombotherapy.com has Semrush global rank of 0. opdivocombotherapy.com has an estimated worth of US$ 868, based on its estimated Ads revenue. opdivocombotherapy.com receives approximately 100 unique visitors each day. Its web server is located in United States, with IP address 165.89.235.20. According to SiteAdvisor, opdivocombotherapy.com is safe to visit. |
Purchase/Sale Value | US$868 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$24 |
Yearly Ads Revenue | US$288 |
Daily Unique Visitors | 6 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
opdivocombotherapy.com. | A | 7198 | IP: 165.89.235.20 |
opdivocombotherapy.com. | NS | 86400 | NS Record: ns1.bms.com. |
opdivocombotherapy.com. | NS | 86400 | NS Record: ns4.bms.com. |
opdivocombotherapy.com. | NS | 86400 | NS Record: ns2.bms.com. |
opdivocombotherapy.com. | NS | 86400 | NS Record: ns3.bms.com. |
opdivocombotherapy.com. | TXT | 86400 | TXT Record: 3bms3jpch6vjk9qjlmh5d55pwx18bx6w |
For U.S. Healthcare Professionals only. Full Prescribing Information OPDIVO Prescribing Information YERVOY Prescribing Information Opdualag Prescribing Information Medication Guide OPDIVO Medication Guide YERVOY Medication Guide Opdualag Medication Guide BMS Connect Patient Site --> SELECT INDICATION Non-Small Cell Lung Cancer (NSCLC) nsclc Metastatic/Recurrent or Early-Stage Neoadjuvant NSCLC (tumors ≥4 cm or node positive) Neoadjuvant NSCLC (tumors ≥4 cm or node positive) 1L mNSCLC (PD-L1 ≥1%) --> 1L mNSCLC (PD-L1 ≥1%) 1L mNSCLC (PD-L1 ≥1%) 1L r/m NSCLC (PD-L1 >1% & <1%) 1L r/m NSCLC (PD-L1 >1% & <1%) 2L mNSCLC 2L mNSCLC View All View All Renal Cell Carcinoma (RCC) rcc Advanced Intermediate or Poor Risk Advanced RCC Advanced RCC --> View All Advanced RCC Indications View All Advanced RCC Indications Gastroesophageal Cancers gastro Metastatic and Adjuvant Adjuvant Treatment of Completely Resected ESO or GEJ Cancer 1L Metastatic Gastric, GEJ, or Esophageal |
HTTP/1.0 301 Moved Permanently Location: http://www.opdivocombotherapy.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 22:08:05 GMT Set-Cookie: CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000 Cache-Control: no-cache,must-revalidate,max-age=0,no-store,private Expires: Thu, 01 Jan 1970 00:00:00 GMT X-Cnection: close Set-Cookie: LSKey-c$CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000 X-XSS-Protection: 1; mode=block Content-Security-Policy: upgrade-insecure-requests Location: https://www.opdivocombotherapy.com/ Connection: close HTTP/1.1 200 OK Date: Sat, 23 Oct 2021 22:08:05 GMT Set-Cookie: CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000 Cache-Control: public,max-age=600 X-Cnection: close Set-Cookie: LSKey-c$CookieConsentPolicy=0:1; domain=na152.salesforce.com; path=/; expires=Sun, 23-Oct-2022 22:08:05 GMT; Max-Age=31536000 Strict-Transport-Security: max-age=31536004; includeSubDomains X-XSS-Protection: 1; mode=block Content-Security-Policy: upgrade-insecure-requests X-Powered-By: Salesforce.com ApexPages P3P: CP="CUR OTR STA" Content-Language: en-US Expires: Sat, 23 Oct 2021 22:18:05 GMT Last-Modified: Sat, 23 Oct 2021 22:08:05 GMT Content-Security-Policy: frame-ancestors 'self' X-FRAME-OPTIONS: SAMEORIGIN Content-Type: text/html;charset=UTF-8 Connection: close |
Domain Name: OPDIVOCOMBOTHERAPY.COM Registry Domain ID: 2469069650_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-12-15T06:08:12Z Creation Date: 2019-12-19T14:26:20Z Registry Expiry Date: 2021-12-19T14:26:20Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BMS.COM Name Server: NS2.BMS.COM Name Server: NS3.BMS.COM Name Server: NS4.BMS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T07:24:01Z <<< |